Blog
Follow us for the latest trends, insights and innovations in the pharmaceutical industry.
Finerenone Drug Class: What Makes This MRA Different from the Rest
Finerenone drug class: third‑generation non‑steroidal MRA. Compare selectivity, potency, half‑life, and safety vs spironolactone/eplerenone. FDA‑approved for CKD+T2D and HF with LVEF ≥40%.
Read More →
Finerenone Mechanism of Action: A Non-Steroidal MRA Built Differently
Finerenone mechanism of action: a non‑steroidal mineralocorticoid receptor antagonist with high MR selectivity, balanced cardiorenal distribution, no active metabolites, and lower hyperkalemia risk vs steroidal ...
Read More →
Clascoterone vs Minoxidil: How They Actually Compare for Hair Loss
Clascoterone vs minoxidil: Compare mechanisms, Phase 3 trial data, side effects, and whether they work better together. Evidence-based overview for hair loss.
Read More →
Finerenone vs Spironolactone: A Head-to-Head Look at Safety and Efficacy
Finerenone vs spironolactone: head-to-head real-world data shows finerenone has 69% lower mortality, 53% fewer kidney events, and less hyperkalemia. Nonsteroidal MRA with no hormonal side ...
Read More →